Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding-Reference-Cited by-同舟云学术

Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding

Published:2011-03-29 Issue:1 Volume:338 Page:22-30
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

André Patrick,DeGuzman Francis,Haberstock-Debic Helena,Mills Scott,Pak Yvonne,Inagaki Mayuko,Pandey Anjali,Hollenbach Stanley,Phillips David R.,Conley Pamela B.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Anticoagulants (Thrombin Inhibitors) and Aspirin Synergize With P2Y 12 Receptor Antagonism in Thrombosis

2. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man.

3. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

4. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic effects of clopidogrel;Purinergic Signalling;2022-06-09

2. The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo;Journal of Clinical Medicine;2021-11-17

3. Clopidogrel treatment inhibits P2Y2-Mediated constriction in the rabbit middle cerebral artery;European Journal of Pharmacology;2021-11

4. Selatogrel, a reversible P2Y12 receptor antagonist, has reduced off-target interference with haemostatic factors in a mouse thrombosis model;Thrombosis Research;2021-04

5. Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y1 and P2Y12 as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor;Journal of Medicinal Chemistry;2020-12-12